First FDA Authorization for Next-Generation Sequencer
Dr. Collins and FDA Commissioner Dr. Margaret Hamburg author an article in the Perspective section of the New England Journal of Medicine, about FDA’s landmark decision to grant marketing authorization for a next-generation sequencer. The article explores how bringing this technology into use for clinical care will transform patient engagement, increase the use of genetic information in health care, and expand research. Collins, Francis S. M.D., Ph.D., and Hamburg, Margaret A., M.D. New England Journal of Medicine.